From the article: "These data highlight the prospect of reinfection with antigenically distinct variants and may foreshadow reduced efficacy of current spike-b

From the article: "These data highlight the prospect of reinfection with antigenically distinct variants and may foreshadow reduced efficacy of current spike-based vaccines." So it suggests that only spike-based vaccines may have reduced efficacy against it. I suppose the inactivated-virus vaccines should be fine. Which would put China and India at huge advantage (https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html https://www.nytimes.com/interactive/2020/science/coronavirus...).